Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia

Guardado en:

Detalles Bibliográficos
Autores principales:	Selçuk Görmez, Ceyda Erel Kırışoğlu, Mehmet Erkan Ekicibaşı, Aleks Değirmencioğlu, Ashok Paudel, Gökçe Akan, Fatmahan Atalar, Nevin Sarıgüzel, Burak Pamukçu
Formato:	article
Lenguaje:	EN TR
Publicado:	KARE Publishing 2021
Materias:	Medicine R Internal medicine RC31-1245 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/cebb9f03edce42c5af55f2bf6803abda
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cebb9f03edce42c5af55f2bf6803abda
record_format	dspace
spelling	oai:doaj.org-article:cebb9f03edce42c5af55f2bf6803abda2021-11-08T18:25:50ZComparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia10.5543/tkda.2021.877501016-5169https://doaj.org/article/cebb9f03edce42c5af55f2bf6803abda2021-06-01T00:00:00Zhttps://archivestsc.com/jvi.aspx?un=TKDA-87750&volume=49&issue=4https://doaj.org/toc/1016-5169Selçuk GörmezCeyda Erel KırışoğluMehmet Erkan EkicibaşıAleks DeğirmencioğluAshok PaudelGökçe AkanFatmahan AtalarNevin SarıgüzelBurak PamukçuKARE PublishingarticleMedicineRInternal medicineRC31-1245Diseases of the circulatory (Cardiovascular) systemRC666-701ENTRTürk Kardiyoloji Derneği Arşivi, Vol 49, Iss 4, Pp 286-292 (2021)
institution	DOAJ
collection	DOAJ
language	EN TR
topic	Medicine R Internal medicine RC31-1245 Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Medicine R Internal medicine RC31-1245 Diseases of the circulatory (Cardiovascular) system RC666-701 Selçuk Görmez Ceyda Erel Kırışoğlu Mehmet Erkan Ekicibaşı Aleks Değirmencioğlu Ashok Paudel Gökçe Akan Fatmahan Atalar Nevin Sarıgüzel Burak Pamukçu Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
format	article
author	Selçuk Görmez Ceyda Erel Kırışoğlu Mehmet Erkan Ekicibaşı Aleks Değirmencioğlu Ashok Paudel Gökçe Akan Fatmahan Atalar Nevin Sarıgüzel Burak Pamukçu
author_facet	Selçuk Görmez Ceyda Erel Kırışoğlu Mehmet Erkan Ekicibaşı Aleks Değirmencioğlu Ashok Paudel Gökçe Akan Fatmahan Atalar Nevin Sarıgüzel Burak Pamukçu
author_sort	Selçuk Görmez
title	Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
title_short	Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
title_full	Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
title_fullStr	Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
title_full_unstemmed	Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
title_sort	comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with covid-19 and non-covid-19 viral pneumonia
publisher	KARE Publishing
publishDate	2021
url	https://doaj.org/article/cebb9f03edce42c5af55f2bf6803abda
work_keys_str_mv	AT selcukgormez comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia AT ceydaerelkırısoglu comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia AT mehmeterkanekicibası comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia AT aleksdegirmencioglu comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia AT ashokpaudel comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia AT gokceakan comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia AT fatmahanatalar comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia AT nevinsarıguzel comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia AT burakpamukcu comparisonofhypertensionprevalenceandtheuseofreninangiotensinaldosteronesystemblockersinhospitalizedpatientswithcovid19andnoncovid19viralpneumonia
_version_	1718441519517532160

Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia

Ejemplares similares